Skip to main content

Mendel and Monsanto Extend Plant Functional Genomics Partnership Through 2011

NEW YORK, July 10 (GenomeWeb News) - Mendel Biotechnology said today that it has extended through 2011 a research and commercialization partnership with Monsanto that began in 1997.
Monsanto and Mendel plan to add a systems biology component to the program, in order to develop "an integrated framework for predictive control of plant gene expression. "
Under the original agreement, Mendel carried out a functional genomics program in Arabidopsis in order to study factors that control plant gene expression. That program identified several genes that have been shown to enhance the yield of major crops in field trials, Mendel said.
These genes are currently in early commercial development by Monsanto and the companies will continue to advance them toward commercialization under the extended agreement.
Mendel will receive milestone and royalty payments from products that Monsanto commercializes.

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.